共 50 条
- [1] Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trialBMC INFECTIOUS DISEASES, 2015, 15Corazon Borja-Tabora, Charissa FayMontalban, CeciliaMemish, Ziad A.Boutriau, DominiqueKolhe, DevayaniMiller, Jacqueline M.Van der Wielen, Marie
- [2] Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Coadministered With Routine Childhood Vaccines in European Infants An Open, Randomized TrialPEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (04) : E98 - E107Merino Arribas, Jose ManuelCarmona Martinez, AlfonsoHorn, MichaelPerez Porcuna, Xavier MariaOtero Reigada, Maria del CarmenMares Bermudez, JosepCenteno Malfaz, FernandoMiranda, MarianoMendez, MariaGarcia Cabezas, Miguel AngelWittermann, ChristophBleckmann, GerhardFischbach, ThomasKolhe, Devayanivan der Wielen, MarieBaine, Yaela
- [3] Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlersHUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (12) : 1892 - 1903Vesikari, TimoForsten, AinoBoutriau, DominiqueBianco, VeroniqueVan der Wielen, MarieMiller, Jacqueline
- [4] Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled studyBMC Infectious Diseases, 13Charissa Borja-TaboraCecilia MontalbanZiad A MemishMarie Van der WielenVeronique BiancoDominique BoutriauJacqueline Miller
- [5] Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled studyBMC INFECTIOUS DISEASES, 2013, 13Borja-Tabora, CharissaMontalban, CeciliaMemish, Ziad A.Van der Wielen, MarieBianco, VeroniqueBoutriau, DominiqueMiller, Jacqueline
- [6] Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults An Open, Randomized TrialPEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (11) : 1236 - 1243Baxter, RogerBaine, YaelaKolhe, DevayaniBaccarini, Carmen I.Miller, Jacqueline M.Van der Wielen, Marie
- [7] Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adultsHUMAN VACCINES, 2011, 7 (02): : 239 - 247Bermal, NancyHuang, Li-MinDubey, A. P.Jain, HermantBavdekar, AshishLin, Tzou-YienBianco, VeroniqueBaine, YaelaMiller, Jacqueline M.
- [8] Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled TrialDRUGS & AGING, 2013, 30 (05) : 309 - 319Dbaibo, GhassanEl-Ayoubi, NabilGhanem, SohaHajar, FarahBianco, VeroniqueMiller, Jacqueline M.Mesaros, Narcisa
- [9] Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled TrialDrugs & Aging, 2013, 30 : 309 - 319Ghassan DbaiboNabil El-AyoubiSoha GhanemFarah HajarVeronique BiancoJacqueline M. MillerNarcisa Mesaros
- [10] Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized studyHUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (06) : 1292 - 1298Anez, GermanHedrick, JamesSimon, Michael W.Christensen, ShaneJeanfreaue, RobertYau, EddyPan, JudyJordanov, EmiliaDhingra, Mandeep S.